What is the primary therapeutic goal in the treatment of cardiogenic shock?

The primary therapeutic goal in the treatment of cardiogenic shock is to increase cardiac output (CO). Cardiogenic shock occurs when the heart is unable to pump effectively, leading to inadequate blood flow to meet the body's needs. Enhancing cardiac output directly addresses the underlying problem by improving the heart's ability to circulate blood, thereby ensuring that vital organs receive sufficient oxygen and nutrients.

Increasing cardiac output can be achieved through various means, including the use of medications such as inotropes that help the heart contract more efficiently. This increase in CO helps stabilize the patient's condition, supports blood pressure, and reduces the risk of organ failure. While stabilizing blood pressure and reducing oxygen demand are important components of managing cardiogenic shock, they are secondary to the primary aim of restoring adequate cardiac output.